Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Posts circulating on social media claim Mamdani is expected to introduce new rules when he becomes New York Mayor in 2026 that will require all public elementary schools in the state to learn Arabic ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

Employers added only 22,000 jobs in August, and the unemployment rate rose slightly to 4.3 percent. Revised data also showed that employment fell by 13,000 jobs in June, the first net loss since ...

This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...

The labor market showed signs of weakening, with 73,000 jobs added in July and gains for the previous two months revised significantly lower. Monthly change in jobs +73,000 jobs in July +300,000 ...